Investigating how certain proteins affect inflammation and Alzheimer's disease.
Role of REV-ERB Proteins in Neuroinflammation and Alzheimer's Disease
This study is looking at how certain proteins might affect sleep patterns and inflammation in the brain, which could help us understand Alzheimer's disease better and find new ways to treat it.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10783065 on NIH RePORTER |
What this research studies
This research explores the role of REV-ERB proteins in the context of Alzheimer's disease and neuroinflammation. It focuses on understanding how disruptions in circadian rhythms may contribute to the progression of Alzheimer's disease. By studying mouse models, the researchers aim to uncover the molecular mechanisms linking circadian dysfunction to neurodegeneration, particularly through the effects of REV-ERB proteins on inflammation and brain health. Patients may benefit from insights that could lead to new therapeutic strategies targeting these pathways.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those experiencing cognitive decline related to neuroinflammation.
Not a fit: Patients with other forms of dementia unrelated to Alzheimer's disease may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that mitigate neuroinflammation and slow the progression of Alzheimer's disease.
How similar studies have performed: Previous research has shown promising results in understanding the relationship between circadian rhythms and neurodegeneration, suggesting that this approach may yield valuable insights.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Musiek, Erik Steven — Washington University
- Study coordinator: Musiek, Erik Steven
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.